Susan M. Swetter, MD, on Molecular Testing for Cutaneous Melanoma

March 22, 2021 By The ASCO Post Staff

Susan M. Swetter, MD, of Stanford Cancer Institute, discusses molecular prognostic tests for cutaneous melanoma, which may improve staging accuracy, reduce unnecessary sentinel lymph node biopsies, and inform decisions on surveillance imaging and/or adjuvant therapy.

Related Content